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Regarding bacterial vaginosis (BV), the relevance of the vaginal microbiota to the
women’s health fulfills a key role, but knowledge gaps regarding aerobic vaginitis
(AV) exist. This study aims to characterize vaginal microbiome and its relationship
with the local immune mediators, providing an opportunity to define the link between
vaginal commensal microorganisms and opportunistic pathogens in the relation of
a given vaginal community state type (CST). A total of 90 vaginal samples from
Caucasian asymptomatic women of reproductive age (18–40 years) attending the yearly
examination and not reporting any vaginal complaints were retrospectively evaluated for
microbiome assessment and immune factor dosage. The samples were tested by the
Ion Torrent PGM and the Luminex Bio-Plex technologies for the analysis of microbiome
and immune factors, respectively. In our study, the CST classification together with the
local immune response profiling represented a good predictive indicator of the vaginal
health, suggesting that the predominance of a specific Lactobacillus and its relative
abundance are pivotal elements to maintain a physiologic status. A vaginal colonization
from Bifidobacterium may absolve a protective role similar to that of Lactobacillus,
corresponding to a newly identified CST, although studies are needed to better clarify
its clinical significance. Moreover, within each CST, a different pattern of inflammation
is activated and orchestrated both by the dominant Lactobacillus spp. and by specific
non-Lactobacillus bacteria and can give insights into the pathogenic mechanisms. In
conclusion, this study contributes to the characterization of vaginal dysbiosis, reshaping
this concept by taking into consideration the CST profiling, local immune marker, and
immune–microbial network.
Keywords: vaginal microbiome, immune proteins, Lactobacillus species, Bifidobacteria, vaginal community state
types
INTRODUCTION
Vaginal dysbiosis consists of a prolonged deviation from a low-diversity, Lactobacilli-dominated
microbiome (Van de Wijgert and Jespers, 2017). Molecular studies have identified different types of
vaginal dysbiosis, of which the most common and best studied is called bacterial vaginosis (BV), an
anaerobic polymicrobial disease associated with subclinical vaginal inflammation (Torcia, 2019).
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Conversely, dysbiotic states that are associated with clinically
overt inflammation include aerobic vaginitis (AV), vaginal
candidiasis, and trichomoniasis (Kenyon et al., 2013; Van
de Wijgert and Jespers, 2017). The association between
dysbiotic microbiota with increased susceptibility to HIV, human
papillomavirus (HPV), and other sexually transmitted infections
(STIs) and increased risk of pelvic inflammatory disease, preterm
birth, and maternal and neonatal infections (Martin et al., 1999;
Guo et al., 2012; Kroon et al., 2018) has been observed.
The microbial composition of vagina differs from that of
other human surfaces and mucosal sites, characterized by a
lower microbial diversity dominated by Lactobacillus species.
These bacteria, acidifying the vaginal environment, play an
important role in local defense (Borges et al., 2014; Aldunate
et al., 2015). Most women have a vaginal microbiome dominated
by Lactobacilli, which are associated with a balanced immune-
tolerant vaginal microenvironment, although not all the species
equally contributed. To be precise, Lactobacillus crispatus
does not induce a vaginal mucosal inflammation, and it is
also associated with protection from pathogens (Donnarumma
et al., 2014). Conversely, Lactobacillus iners is much more
easily displaced from the vaginal mucosa and often co-occurs
with dysbiosis-associated microbes and inflammatory process
(Macklaim et al., 2013). A not-well-identified role has been
attributed for Lactobacillus gasseri and Lactobacillus jensenii
(Forney et al., 2006; Borges et al., 2014). It has been shown
that particular bacterial species are able to colonize both the
gastrointestinal and reproductive tract of women, suggesting
the rectum as the origin of bacteria commonly colonizing
the vagina (Freitas and Hill, 2017). AV is a different vaginal
condition with respect to BV, with a specific clinical management
and distinct clinical risks (Donders et al., 2011). AV is
characterized by a decrease in the amount of Lactobacillus but,
unlike BV, is accompanied by severe inflammation and the
presence of mainly aerobic enteric species, including Group
B Streptococcus (Streptococcus agalactiae), Enterococcus faecalis,
Escherichia coli, and Streptococcus aureus (Fredricks et al., 2005;
Ghartey et al., 2014; Kaambo et al., 2018). The diagnosis of
AV is performed by microscopy on wet mount, using a scoring
system. The AV score may indicate normal, intermediate, or
severe AV, dominated by an increase grade of inflammation
severity (Anahtar et al., 2015). Nevertheless, these methods
showed some limitations such as the impossibility of discerning
between Lactobacillus spp. and bacterial species. Thus, it is
difficult to make a differentiated diagnosis between AV and
BV, causing the implementation of incorrect treatments, with
further consequences including desquamative inflammatory
vaginitis, preterm delivery, chorioamnionitis, and funisitis of the
fetus during pregnancy (Donders et al., 2002, 2017; Reichman
and Sobel, 2014). Considering the relevance of the vaginal
microbiota to women’s health and the existing knowledge
gap regarding AV, the study of vaginal microbiome and its
relationship with the local immune mediators will provide an
opportunity to define the link between vaginal commensal
microorganisms and opportunistic pathogens in relation to
a given vaginal community state type (CST; Kaambo et al.,
2018). Such studies will contribute to the characterization
of AV and BV dysbiosis and may well inform about the
importance of the immune–microbial specific network in
identifying dysbiosis.
MATERIALS AND METHODS
Demographics of the Studied Cohort
Ninety vaginal swabs from Caucasian asymptomatic women of
reproductive age (18–40 years) were retrospectively evaluated
for microbiome assessment and immune factor dosage. Vaginal
swabs were performed during the yearly examination from
asymptomatic women who did not report any vaginal complaints.
The exclusion criteria were >40 years old, menstrual flow,
sexual intercourses in the last 3 days, pregnancy, menopause,
antibiotic/probiotic therapy in the last 3 months, hormonal
therapy, any contraceptive methods (such as condom, pills,
vaginal ring, and intrauterine device), and known history of STIs.
Ethics Statement
The study was approved by the Institutional Scientific Board
of the Institute for Maternal and Child Health—IRCCS “Burlo
Garofolo” of Trieste, Italy (RC 26/13). All procedures performed
in this study involving human participants were in accordance
with the ethical standards of the institutional and/or national
research committee and with the 1964 Declaration of Helsinki
and its later amendments or comparable ethical standards.
Informed consent was obtained from all the participants
included in the study.
DNA Extraction and Next-Generation
Sequencing (NGS) Library Preparation
Bacterial DNA was extracted using the NucliSENS R© easyMAG R©
system (BioMèrieux, Gorman, NC, United States), following the
manufacturer’s instructions, starting from 500 µl and with a
final elution volume of 50 µl. Briefly, a 500-base-pair region of
the V1–V3 portion of the 16S rRNA gene and, subsequently,
the 200-base-pair region of the V3 portion was amplified, as
elsewhere described (Campisciano et al., 2018). The V3 amplicon
was used for template preparation by the Ion PGM Hi-Q View
kit on the Ion OneTouchTM 2 System (Life Technologies, Grand
Island, NY, United States) and sequenced using the Ion PGM
Hi-Q View sequencing kit (Life Technologies, Grand Island, NY,
United States) with the Ion PGMTM System technology. Negative
controls, including a no-template control, were processed with
the clinical samples.
Dosage of the Immune Soluble Factors
A soluble concentration of 48 cytokines, chemokines, and
growth factors was assessed in duplicate in all 90 vaginal swabs
using magnetic bead-based multiplex immunoassays (Bioplex
ProTM human cytokine 21-plex and 27-plex panel, Bio-Rad
Laboratories, Milan, Italy) according to the pre-optimized
protocol (Zanotta et al., 2019). In brief, the undiluted samples
(50µl) were mixed with biomagnetic beads in 96-well flat-bottom
plates, and after incubation for 30 min at room temperature
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followed by washing plate with Bio-Plex wash buffer, 25 µl
of the antibody–biotin reporter was added. After the addition
of 50 µl of streptavidin–phycoerythrin (PE) and following
incubation for 10 min, the concentrations of the cytokines
were determined using the Bio-Plex-200 system (Bio-Rad Corp.,
United States) and Bio-Plex Manager software (v.6, Bio-Rad).
The data were expressed as median fluorescence intensity (MFI)
and concentration (pg/ml).
Bioinformatics Analysis
Raw sequences were analyzed by using QIIME 1.9.1 software
(Caporaso et al., 2010). To optimize the operational taxonomic
unit (OTU) detection, reads with an average quality score lower
than 20, shorter than 150 bp, and with length of homopolymer
>6 and primer mismatches >0 were excluded from the analysis.
To reduce the risk of including OTUs that were PCR artifacts, all
OTUs that occurred in only one sample were removed. The OTUs
defined by a 97% of similarity were assigned using the Vaginal
16S rRNA gene Reference Database, which was constructed by
Fettweis et al. (2012), using open-reference OTU picking with a
uclust clustering tool. To control for differences in sequencing
depth between samples, we normalized the read counts by
rarefying the otu table biom to a depth of 5,000 reads/sample.
Statistical Analysis
Stata (v. 13.1) and GraphPad Prism (v. 5) were used for statistical
data analysis of the immune soluble factors. The Kruskal–Wallis
one-way analysis of variance was used for comparisons between
groups. When a significant p-value was observed (p < 0.05), a
multiple comparison test was used to determine which groups
were different. To survey the association between microbial
identities and the increase or decrease of specific immune
factors, the observation_metadata_correlation.py script (with
bootstrapped p-value assignment and based on the Pearson
score) of QIIME was used.
Accession Numbers
The dataset has been deposited in the National Center for
Biotechnology Information (NCBI) Sequence Read Archive
(SRA) under the project number SRP152778.
TABLE 1 | The results of the sample grouping.
Group No. of samples (%)
CST I 18 (21)
CST II 13 (15)
CST III 28 (33)
CST IV 22 (25)
Mixed CST 3 (3.5)
Bifidobacteria 2 (2.5)
For the grouping, the output of the taxa_summary.py on the rarefied otu_table.biom
(5,000 reads/sample) was used, excluding four samples from the total number
(n tot = 90). The community state types (CSTs) were named on the basis of
the dominant Lactobacillus. Mixed CSTs are characterized by two predominant
Lactobacilli whereas the Bifidobacteria group by Bifidobacterium spp.
TABLE 2 | Description of the microbial composition.
CST Microbiome
I 13% Ureaplasma parvum, 87% L. crispatus
I 25% Gardnerella vaginalis, 39% L. crispatus
I 25% G. vaginalis, 1% U. parvum, 15% L. crispatus
I 1% Prevotella timonensis, 22% L. crispatus
I 28% Atopobium vaginae, 27% Bifidobacterium breve, 4%
U. parvum, 15% L. crispatus
I 1% U. parvum, 58% L. crispatus
II 22% G. vaginalis, 75% L. gasseri
II 19% G. vaginalis, 17% U. parvum, 64% L. gasseri
II 22% G. vaginalis, 12% U. parvum, 65% L. gasseri
II 9% G. vaginalis, 5% U. parvum, 83% L. gasseri
II 6% G. vaginalis, 5% U. parvum, 24% L. gasseri
II 4% A. vaginae, 21% G. vaginalis, 65% L. gasseri
II 36% Alloscardovia omnicolens, 2% Bifidobacterium bifidum, 62%
L. gasseri
II 61% Escherichia fergusonii, 39% L. gasseri
II 46% B. breve, 3% Streptococcus agalactiae, 48% L. gasseri
II 1% Gemella haemolysans, 5% Staphylococcus haemolyticus, 9%
Streptococcus australis, 30% Streptococcus salivarius, 1%
Streptococcus sinensis, 1% Klebsiella variicola, 45% L. gasseri
II 1% S. agalactiae, 4% Lachnospira pectinoschiza, 1% Dialister
micraerophilus, 80% L. gasseri
II 30% B. breve, 16% Bifidobacterium scardovii, 1% L. pectinoschiza,
50% L. gasseri
II 14% Lactobacillus acidophilus, 1% L. crispatus, 34%
Lactobacillus delbrueckii, 48% L. gasseri
III 4% G. vaginalis, 1% U. parvum, 93% L. iners
III 3% G. vaginalis, 91% L. iners
III 7% G. vaginalis, 86% L. iners
III 22% G. vaginalis, 2% U. parvum, 5% Aerococcus christensenii,
76% L. iners
III 2% U. parvum, 96% L. iners
III 18% G. vaginalis, 81% L. iners
III 7% U. parvum, 22% S. agalactiae, 71% L. iners
III 5% E. fergusonii, 92% L. iners
III 3% Prevotella melaninogenica, 4% Prevotella veroralis, 1%
S. haemolyticus, 89% L. iners
III 1% U. parvum, 97% L. iners
III 8% Prevotella disiens, 2% P. timonensis, 5% A. christensenii, 6%
Acidaminococcus fermentans, 2% D. micraerophilus, 4%
L. acidophilus, 73% L. iners
IV 1% Eggerthella sinensis, 2% Prevotella amnii, 2% Prevotella shahii,
5% P. timonensis, 85% BVAB2, 2% Veillonella montpellierensis
IV 6% A. vaginae, 1% E. sinensis, 10% G. vaginalis, 5% Sneathia
sanguinegens, 47% P. timonensis, 2% A. christensenii, 4%
D. micraerophilus, 6% V. montpellierensis, 5% Parvimonas micra,
4% L. iners
IV 3% P. bennonis, 3% P. somerae, 6% P. timonensis, 1% Tissierellia
coagulans, 2% D. propionicifaciens, 1% A. tetradius, 2% P. ivorii,
3% C. ureolyticus, 74% E. fergusonii
IV 10% A. vaginae, 3% E. sinensis, 10% G. vaginalis, 2%
Fusobacterium equinum, 17% S. sanguinegens, 2% U. parvum,
11% Prevotella bivia, 18% P. disiens, 4% P. timonensis, 4%
Gemella palaticanis, 3% Peptoniphilus stomatis, 3%
D. micraerophilus, 8% V. montpellierensis, 3% L. iners
IV 7% A. vaginae, 1% E. sinensis, 18% G. vaginalis, 18%
S. sanguinegens, 8% P. amnii, 23% P. timonensis, 3%
D. micraerophilus, 4% V. montpellierensis, 2% P. micra, 9% L. iners
(Continued)
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TABLE 2 | Continued
CST Microbiome
IV 3% A. vaginae, 94% G. vaginalis
IV 14% A. vaginae, 2% E. sinensis, 34% S. sanguinegens, 28%
P. amnii, 1% P. timonensis, 1% D. micraerophilus, 6%
V. montpellierensis, 12% L. iners
IV 23% A. vaginae, 6% G. vaginalis, 44% P. bivia, 10%
V. montpellierensis, 17% L. iners
IV 74% G. vaginalis, 3% D. micraerophilus, 2% Lactobacillus casei,
4% L. gasseri, 15% Lactobacillus johnsonii
IV 12% A. vaginae, 9% G. vaginalis, 29% P. bivia, 3% Prevotella oris,
4% P. timonensis, 3% P. stomatis, 3% D. micraerophilus, 2%
Finegoldia magna, 3% L. gasseri, 28% L. iners
IV 98% S. agalactiae, 1% D. micraerophilus
IV 86% Staphylococcus pasteuri, 5% Staphylococcus simiae, 1%
Enterococcus faecalis, 3% S. agalactiae, 5% E. fergusonii
IV 92% A. vaginae, 4% E. fergusonii
IV 31% E. fergusonii, 34% Klebsiella granulomatis, 33% K. variicola,
IV 2% A. vaginae, 60% Streptococcus anginosus, 37% S. simiae
IV 83% Corynebacterium pyruviciproducens, 1% Fusobacterium
naviforme, 2% Prevotella pallens, 3% D. micraerophilus, 3%
E. fergusonii
IV 3% S. anginosus, 6% A. omnicolens, 1% Bifidobacterium longum,
18% L. acidophilus, 70% L. delbrueckii bulgaricus
IV 83% Citrobacter braakii, 2% E. fergusonii, 7% K. granulomatis, 2%
K. variicola, 4% Staphylococcus blattae, 2% Pseudomonas
aeruginosa
IV 77% Staphylococcus massiliensis, 4% Anaerococcus hydrogenalis,
15% F. magna, 3% E. fergusonii
IV 30% S. anginosus, 38% A. omnicolens, 27% P. bivia, 6%
D. micraerophilus
IV 35% A. omnicolens, 38% S. haemolyticus, 2% Staphylococcus
lugdunensis, 2% S. simiae, 7% S. agalactiae, 8%
D. micraerophilus, 4% Aureimonas altamirensis
IV 8% P. disiens, 2% P. timonensis, 5% A. christensenii, 6%
A. fermentans, 2% D. micraerophilus, 4% L. acidophilus, 73%
L. iners
I/II 21% A. vaginae, 11% P. bivia, 1% L. pectinoschiza, 23%
E. fergusonii, 24% L. gasseri, 15% L. crispatus
I/III 46% L. crispatus, 52% L. iners
I/III 31% L. crispatus, 68% L. iners
Bifido 98% B. breve
Bifido 19% B. breve, 2% G. vaginalis, 1% L. pectinoschiza, 60%
L. delbrueckii
The relative abundances of the bacterial species are the output of the
taxa_summary.py script on the rarefied out_table.biom (5,000 reads/sample). For
brevity, the samples belonging to CST I in which Lactobacillus crispatus and
samples belonging to CST III in which Lactobacillus iners were uniquely identified
are omitted. Community state type I (CST I) is characterized by L. crispatus, CST
II by Lactobacillus gasseri, and CST III by L. iners, and CST IV is not characterized
by a Lactobacillus. Bifido, bifidobacteria. In bold, the identified Lactobacilli species.
RESULTS
Characterization of the Microbial Profile
From the sequencing of the V3 region of the 16S rRNA
gene, we obtained a total of 5,683,700 reads (range 1,278–
190,380) and a total number of observed OTUs of 11,168
(the reads were clustered into 100 ± 46 OTUs per sample).
For the analyses, we rarefied the otu_table.biom to a depth
of 5,000 reads/samples, excluding four samples. The two
negative controls did not produce an output after the quality
filtering. For samples clustering, we used pairwise Bray–
Curtis dissimilarities as the input, using Ward’s method for
hierarchical clustering. According to the CST classification
(Ravel et al., 2011), we identified 18 samples belonging to CST
I characterized by Lactobacillus crispatus, 13 samples belonging
to CST II characterized by Lactobacillus gasseri, 28 samples
belonging to CST III characterized by Lactobacillus iners, and
22 belonging to CST IV depleted of or with low amount of
Lactobacilli. Three samples showed two dominant Lactobacilli
at an equal amount, defined as mixed CST. In one sample,
L. crispatus and L. gasseri were present, whereas in the other
two samples, L. crispatus and L. iners. Finally, two remaining
samples showed the massive presence of Bifidobacteria with
respect to the other samples (Table 1). The non-Lactobacillus
bacteria that were identified within each CST are detailed
in Table 2. In particular, in six out of 18 CST I samples,
the presence of Gardnerella vaginalis, Ureaplasma parvum,
Prevotella timonensis, Atopobium vaginae, and Bifidobacterium
bifidum was spotted. In the remaining samples belonging
to CST I, the relative abundance of L. crispatus was higher
than 90%. In 12 out of 13 CST II and in 10 out of 28 CST
III samples, several non-Lactobacillus species were present
(Table 2). In the remaining samples of CST III, the L. iners was
above the 98% relative abundance. The 22 CST IV samples
showed a highly heterogeneous microbial composition;
and the Lactobacillus species identified were L. iners,
Lactobacillus acidophilus, L. gasseri, Lactobacillus delbrueckii,
and Lactobacillus casei.
Significant Associations Between
Immune Soluble Factors and Bacteria
The concentrations of soluble immune proteins were measured
in all 90 vaginal swabs to explore the changes of local immune
response associated with different microbial compositions,
observed in the different CST cohorts. As shown in Figure 1,
macrophage colony-stimulating factor (M-CSF) was correlated to
several microorganisms (observation_metadata_correlation.py
script, p < 0.05), including BVAB2, Citrobacter braakii,
Dialister micraerophilus, Klebsiella granulomatis, Megasphaera
paucivorans, and Streptococcus agalactiae. Moreover, the highest
amount of M-CSF was observed in CST III, and it was
significantly modulated compared with that in CST I (p < 0.05).
Figure 2 shows the inflammasome-dependent immune network
associated with L. crispatus, L. iners, Alloscardovia omnicolens,
Escherichia fergusonii, Prevotella bivia, Streptococcus anginosus,
U. parvum, and P. timonensis. CST IV showed a significant
increase of two pro-inflammatory cytokines, interleukin (IL)-
1α (p < 0.05) and IL-18 (p < 0.001), compared to the
CST I. Only the concentration of IL-18 resulted significantly
higher in CST IV compared with CST III (p < 0.05). The
anti-inflammatory cytokine IL-1ra resulted in an association
with L. crispatus, L. iners, and U. parvum (Figure 2). The
inflammatory proteins IL-1β and hepatocyte growth factor
(HGF) showed an increased trend level in the CST III cohort,
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FIGURE 1 | Generic marker of dysbiosis. According to the Pearson correlation score, M-CSF significantly (FDR p-value <0.001) correlated with several
microorganisms. The association was calculated by means of the observation_metadata_correlation.py script on the rarefied otu_table.biom (5,000 reads/sample).
The amount of M-CSF also varied based on the community state type (CST). The comparisons were performed by means of a Kruskal–Wallis one-way analysis of
variance. When a significant p-value was observed (p < 0.05), a multiple comparison test was used to determine which groups were different. The data are shown
as the mean value ±standard error of the mean (SEM). Pearson scores for every bacterial species are shown in brackets. FDR, false discovery rate; M-CSF,
macrophage colony-stimulating factor. ∗p < 0.05.
FIGURE 2 | Inflammasome-dependent pathway. According to the Pearson correlation score, components belonging to the inflammasome complex significantly
(FDR p-value <0.001) correlated with several microorganisms. The association was calculated by means of the observation_metadata_correlation.py script on the
rarefied otu_table.biom (5,000 reads/sample). The amount of IL-1α and IL-18 varied based on the community state type (CST). The comparisons were performed by
means of a Kruskal–Wallis one-way analysis of variance. When a significant p-value was observed (p < 0.05), a multiple comparison test was used to determine
which groups were different. The data are shown as the mean value ± standard error of the mean (SEM). Pearson scores for every bacterial species are shown in
brackets. FDR, false discovery rate. ∗p < 0.05, ∗∗∗p < 0.001.
and these resulted in an association only with P. timonensis
(Figure 2). Conversely, Figure 3 shows the inflammasome
non-dependent immune network associated with Lactobacillus
iners and U. parvum (Pearson pval_fdr < 0.001). Although
no immune protein of this panel showed a statistically
significant concentration difference, we observed a higher
level of both immune factors macrophage migration inhibitory
factor (MIF) and tumor necrosis factor alpha (TNF-α) in CST
IV with respect to other cohorts, and both were associated
with L. iners.
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FIGURE 3 | Inflammasome-independent pathway. According to the Pearson correlation score, some pro-inflammatory soluble immune factors (FDR p-value <0.001)
correlated with Lactobacillus iners and Ureaplasma parvum. The association was calculated by means of the observation_metadata_correlation.py script on the
rarefied otu_table.biom (5,000 reads/sample). The amount of these molecules did not vary based on the community state type (CST). The comparisons were
performed by means of a Kruskal–Wallis one-way analysis of variance. When a significant p-value was observed (p < 0.05), a multiple comparison test was used to
determine which groups were different. The data are shown as the mean value ±standard error of the mean (SEM). Pearson scores for every bacterial species are
shown in brackets. FDR, false discovery rate.
DISCUSSION
The introduction of the non-culture-based techniques
has highlighted a broad spectrum of vaginal microbiome
composition in women of reproductive age (Campisciano
et al., 2017). In our study, the CST classification (Ravel et al.,
2011) together with the profiling of the local immune response
represented a good predictive indicator of the vaginal health,
suggesting that not only the predominance of a specific
Lactobacillus but also its relative abundance were pivotal
elements to maintain a physiologic status. To be precise,
for Lactobacillus crispatus and Lactobacillus iners, a relative
abundance >90% and >98%, respectively, seems to be required
to exclude non-commensal microorganisms. Conversely, in
our cohort, Lactobacillus gasseri is often accompanied with
commensal and non-commensal microorganisms, despite
its relative abundance. Furthermore, the importance of
the Lactobacillus species and of its relative abundance
is also supported by the absence or the low amount of
Lactobacilli in the samples belonging to CST IV, also
known as the BV-like vaginal microbiome (Torcia, 2019).
In two samples of our series, we observed a vaginal
microbiota characterized by a massive colonization of
Bifidobacterium compared with that of the other samples.
It is known that Bifidobacteria are able to equally colonize
the vagina and the gut, where they exert beneficial roles,
such as lactic acid production (Sugahara et al., 2015).
A recent study has identified vaginal profiles dominated
by Bifidobacterium in healthy reproductive-aged women,
suggesting a potential protective role of these bacteria similar
to that of Lactobacillus (Freitas and Hill, 2017). Therefore, the
presence of Bifidobacterium in place of Lactobacillus could
correspond to a newly identified CST. Although, owing to
the paucity of samples with Bifidobacterium colonization
in our cohort, studies are needed to better clarify its
clinical significance.
In our series, the relationship of microbiome composition
with immune mediators showed the significant increase in
the concentration of the protein M-CSF in CST III with
respect to CST I (p < 0.05), although this protein was
associated with pathogens identified from both CST III
and CST IV cohorts (Figure 1). As M-CSF induces the
proliferation of monocytes/macrophages and stimulates their
phagocytic activity, it seems to represent a non-specific
marker of dysbiosis. Nevertheless, the bacterial microbiome
composition modulates alternative specific responses, one
dependent on the inflammasome complex (Figure 2) and one
on the inflammasome-independent pro-inflammatory cytokine
secretion (Figure 3), underlining its key role in activating
different grades of inflammation. On this way, the commensals
L. crispatus, L. iners, and Ureaplasma parvum are associated with
the pro-inflammatory inflammasome molecules IL-1α and IL-18
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concomitantly with the antagonist IL-1ra, generating a balance
between anti-inflammatory and pro-inflammatory response.
This equilibrium is unbalanced by the presence of pathogens,
which diverts it toward the inflammation. Pathogens such
as Alloscardovia omnicolens, Escherichia fergusonii, Prevotella
bivia, and Streptococcus anginosus, usually considered bacteria
responsible of AV, are associated with IL-18 but not with the
anti-inflammatory molecule (Strömbeck et al., 2007; Elovitz
et al., 2019; Han et al., 2019). Although this mechanism is
common to several pathogens, a specific pattern is described for
Prevotella timonensis, which induces the release of IL-1β, another
inflammasome molecule that is known to increase the amount of
HGF (Lönn et al., 2014; Bao et al., 2015). Several bacteria, such
as Pseudomonas aeruginosa and Helicobacter pylori, hijack the
HGF cascade signaling to establish a comfortable environment
for the infection (Strömbeck et al., 2007). Thus, in the vaginal
environment, the dosage of HGF can be considered a biomarker
of the presence of Prevotella (Figure 2). In this study, a massive
colonization of L. iners and U. parvum has been observed
that, although vaginal commensals, can induce a baseline
inflammation through an inflammasome-independent pathway
(Figure 3). To be precise, U. parvum is associated with IL-
2, which induces the release of interferon gamma (IFN-γ),
and L. iners is additionally associated with IL-12p70, which
stimulates the increased amount of TNF-α (Kasprzykowska et al.,
2014). L. iners is also associated with MIF, which is known
to activate T-cell proliferation and to stimulate the release of
TNF-α and IL-2 (Liang et al., 2018). This mechanism could
explain why many authors report that a vaginal microbiota
belonging to CST III, dominated by L. iners, has a higher baseline
inflammation with respect to that of CST I and CST II (Ravel
et al., 2011; Kacerovsky et al., 2015). Moreover, the increasing
trend of pro-inflammatory factors such as MIF and TNF-α in
CST IV (Figure 3), although not significant, might indicate
the establishment of an inflammatory state associated with the
absence or the low amount of Lactobacilli, as it has been reported
for BV. Therefore, as already disclosed by several studies, the total
Lactobacilli load in the vagina without considering the bacterial
species is not an accurate parameter to assert the health status
(Biagi et al., 2009; Jespers et al., 2012). Based on this observation,
the introduction of CSTs has led to the comprehension that
the species of Lactobacilli differently and not equally exert a
protective role in the invasion of pathogens (Parolin et al., 2018).
In addition, we demonstrate that within each CST, a different
pattern of inflammation is activated and orchestrated both by
the dominant Lactobacillus spp. and by specific non-Lactobacillus
bacteria and can give insights into the pathogenic mechanisms. In
conclusion, we should reshape our concept of dysbiosis by taking
into consideration the CST profiling, local immune marker, and
immune–microbial network.
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